Suchergebnisse - "IgG"

PubPharm (1.593)

1

A low-temperature SPR-based assay for monoclonal antibody galactosylation and fucosylation assessment using FcγRIIA/B

enthalten in: Biotechnology and bioengineering | 2024

von Gaudreault, J. | Forest-Nault, C. | Gilbert, M. | +3

2

Combining Cellular Immunization and Phage Display Screening Results in Novel, FcγRI-Specific Antibodies

enthalten in: Viruses | 2024

von Krohn, S. | Holtrop, T. | Brandsma, A. | +7

3

Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells

enthalten in: Nature | 2024

von Guan, X. | Hu, R. | Choi, Y. | +28

ErratumIn: Nature. 2024 Mar 13;:. - PMID 38480897

4

Interactions of the anti-FcRn monoclonal antibody, rozanolixizumab, with Fcγ receptors and functional impact on immune cells in vitro

enthalten in: mAbs | 2024

von Qureshi, O. | Sutton, E. | Bithell, R. | +10

5

Benchmarking glycoform-resolved affinity separation - mass spectrometry assays for studying FcγRIIIa binding

enthalten in: Frontiers in immunology | 2024

von Gstöttner, C. | Lippold, S. | Hook, M. | +6

6

Systematic evaluation of AML-associated antigens identifies anti-U5 SNRNP200 therapeutic antibodies for the treatment of acute myeloid leukemia

enthalten in: Nature cancer | 2023

von Knorr, K. | Rahman, J. | Erickson, C. | +23

7

ATOR-1017 (evunzekibart), an Fc-gamma receptor conditional 4-1BB agonist designed for optimal safety and efficacy, activates exhausted T cells in combination with anti-PD-1

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von Enell Smith, K. | Fritzell, S. | Nilsson, A. | +9

8

Features and protective efficacy of human mAbs targeting Mycobacterium tuberculosis arabinomannan

enthalten in: JCI insight | 2023

von Liu, Y. | Chen, T. | Zhu, Y. | +6

9

Inhibiting N-glycan processing increases the antibody binding affinity and effector function of human natural killer cells

enthalten in: Immunology | 2023

von Rodriguez Benavente, M. | Hughes, H. | Kremer, P. | +2

10

FcγRIIB expressed on CD8+ T cells limits responsiveness to PD-1 checkpoint inhibition in cancer

enthalten in: Science translational medicine | 2023

von Bennion, K. | Tariq, M. | Wyatt, M. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[160]